Product information and disease descriptionProduct descriptionProduct information
Co-prescribed/Concomitant therapies
7 evidence topics · 5 sources
Positive airway pressure: initiation permitted during the phase 3 trials
“Participants are not prohibited from initiating PAP during the trial if deemed by the participant's primary care provider to be in the participant's best medical interest. Dosing of AD109 or placebo can continue if PAP is initiated.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Allowed and disallowed concomitant medications in the phase 3 trials
“Inhaled corticosteroid, and antidiabetics, including those associated with weight loss” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Drugs used exclusively for weight loss” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Modafinil, armodafinil, solriamfetol, and pitolisant” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Benzodiazepines, Z-drugs, DORAs, and trazodone” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote